Study ID: KT621-AS-203
KT-621 Long-Term Extension for Asthma
Sponsored by Kymera Therapeutics, Inc.
Official Study Title
A Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Safety and Tolerability of KT-621 in Participants With Asthma Previously Enrolled in a KT-621 Asthma Study
Sponsor
Kymera Therapeutics, Inc.
Phase
Long-Term Extension
Indication
Asthma (long-term extension for prior KT-621 participants)
Duration
Long-term extension
About This Study
Objective
To evaluate the long-term safety and tolerability of KT-621 in participants with asthma.
Who Can Participate
Key Eligibility Criteria
Below are the main inclusion and exclusion criteria for this study. The full eligibility assessment will be discussed with you by our research team during screening.
Key Inclusion Criteria
- Previously enrolled in a KT-621 asthma study
- Eligible per protocol for continued participation
Key Exclusion Criteria
- Per study protocol — contact study team for details
Get Started
Apply for this study
Fill out the form below to see if you qualify. Our research coordinators will contact you directly to discuss your eligibility — there's no obligation to participate.
Your information is kept confidential and only used for study eligibility purposes.
Why Participate
Advancing research, one participant at a time.
Clinical trials depend on volunteers like you. By participating, you gain access to potential new treatments while helping researchers discover safer, more effective therapies for everyone.
- Access to investigational treatments and expert medical care
- Close monitoring by our experienced research team
- Contribute to better treatments for future patients
- Confidential — your information is protected at every step